MOORE JOHN R (General Counsel) sold 22.1% of their position (5.02K shares) of EDGEWISE THERAPEUTICS, INC. on the open market

Open‑market sale worth $219.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 4 sales

MOORE JOHN R

Filed: 8/14/2026ACC: 0001191702-26-000001

InsiderMOORE JOHN RCIK 1191702

→

IssuerEDGEWISE THERAPEUTICS, INC.CIK 1710072

Officer· General Counsel

Since Mar 2021

+92.48K

Net shares

Net buyer

$219.8K

Total sold

Open market trades

0B · 4S

Total transactions

110K acquired · 17.52K disposed

Non-Derivative Transactions6

Common Stock

Direct

M · Option Exercise

+5.78K

Price / share

—

Trade value

—

% of position

56.6%

8/12/2026

10.21K→15.99K

Common Stock

Direct

M · Option Exercise

+6.72K

Price / share

—

Trade value

—

% of position

42.0%

8/12/2026

15.99K→22.71K

Common Stock

Direct

S · Sale

−2.44K

Price / share

$43.81

Trade value

$106.85K

% of position

10.7%

8/12/2026

22.71K→20.27K

Common Stock

Direct

S · Sale

−59.00

Price / share

$44.41

Trade value

$2.62K

% of position

0.3%

8/12/2026

20.27K→20.21K

Common Stock

Direct

S · Sale

−99.00

Price / share

$44.50

Trade value

$4.41K

% of position

0.5%

8/12/2026

20.21K→20.12K

Common Stock

Direct

S · Sale

−2.42K

Price / share

$43.80

Trade value

$105.95K

% of position

12.0%

8/12/2026

20.12K→17.70K

Total

Net shares

+7.48K

Net value

-$219.82K

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Direct	8/12/2026	M · Option Exercise	+5.78K	—	—	56.6%	10.21K	15.99K
Common Stock Direct	8/12/2026	M · Option Exercise	+6.72K	—	—	42.0%	15.99K	22.71K
Common Stock Direct	8/12/2026	S · Sale	−2.44K	$43.81	$106.85K	10.7%	22.71K	20.27K
Common Stock Direct	8/12/2026	S · Sale	−59.00	$44.41	$2.62K	0.3%	20.27K	20.21K
Common Stock Direct	8/12/2026	S · Sale	−99.00	$44.50	$4.41K	0.5%	20.21K	20.12K
Common Stock Direct	8/12/2026	S · Sale	−2.42K	$43.80	$105.95K	12.0%	20.12K	17.70K
Total			+7.48K		-$219.82K

Derivative Transactions4

Restricted Stock Units

Direct

M · Option Exercise

Converts to

Common Stock

5.78K shares

−5.78K

Strike price

0.00

Held after

11.56K

Exercisable

—

8/12/2026

Restricted Stock Units

Direct

M · Option Exercise

Converts to

Common Stock

6.72K shares

−6.72K

Strike price

0.00

Held after

20.16K

Exercisable

—

8/12/2026

Restricted Stock Units

Direct

A · Award

Converts to

Common Stock

32.50K shares

+32.50K

Strike price

0.00

Held after

32.50K

Exercisable

—

8/12/2026

Stock Option (Right to Buy)

Direct

A · Award

Converts to

Common Stock

65K shares

+65K

Strike price

0.00

Held after

65K

Exercisable

—

8/12/2026

Security	Converts To	Date	Type	Shares	Exercisable	Held After
Restricted Stock Units Direct	Common Stock5.78K shares	8/12/2026	M · Option Exercise	−5.78K	—	11.56K
Restricted Stock Units Direct	Common Stock6.72K shares	8/12/2026	M · Option Exercise	−6.72K	—	20.16K
Restricted Stock Units Direct	Common Stock32.50K shares	8/12/2026	A · Award	+32.50K	—	32.50K
Stock Option (Right to Buy) Direct	Common Stock65K shares	8/12/2026	A · Award	+65K	—	65K